肌肉脂肪变性而非肌肉减少症使NAFLD患者易患早期脂肪性肝炎和纤维化进展
在一项338例经活检证实的前瞻性NAFLD队列中,严重肌肉脂肪变性(按性别分层MA最低四分位定义)与早期NASH相关(OR 2.45,95%CI 1.24-4.86),并与纤维化进展相关(HR 2.49,95%CI 1.15-5.40)。肌肉减少症与早期NASH无显著关联。
要点
- 早期NASH患者MA低于NAFL患者(45.61±6.45 vs 47.48±5.85 HU,P=.028),骨骼肌指数相似。
- 严重肌肉脂肪变性在早期NASH中患病率高于NAFL(33.3% vs 21.1%,P=.029)。
- 严重肌肉脂肪变性是早期NASH的独立相关因素(OR 2.45,95%CI 1.24-4.86)。
核心结论
- 严重肌肉脂肪变性与早期NAFLD的早期NASH及纤维化进展显著相关。
研究设计与样本
- 从一项经活检证实的前瞻性NAFLD队列(N=338)中选取无显著纤维化的非酒精性脂肪肝(NAFL)或早期非酒精性脂肪性肝炎(NASH)患者。
- 使用第三腰椎水平的腹部脂肪计算机断层扫描测量骨骼肌指数和平均肌肉衰减(MA)。
- 严重肌肉脂肪变性定义为按性别分层MA值的最低四分位。
主要发现
- 早期NASH患者(n=87)MA低于NAFL患者(n=251)(45.61±6.45 vs 47.48±5.85 HU;P=.028),骨骼肌指数相似。
- 小叶炎症和肝细胞气球样变更严重的患者MA更低(分别为P=.003和P=.041)。
- 严重肌肉脂肪变性患病率在早期NASH中高于NAFL(33.3% vs 21.1%;P=.029)。
- 校正年龄、性别和代谢因素后,严重肌肉脂肪变性者更可能患早期NASH(OR 2.45;95%CI 1.24-4.86),进一步校正内脏脂肪量后仍保持(OR 2.44;95%CI 1.22-4.89)。
- 中位随访29个月期间,170例患者重复接受瞬时弹性成像;分别有28例和31例出现纤维化进展(定义分别为肝硬度测量值增加>2 kPa或第二次肝硬度测量值≥7 kPa),校正多种混杂因素后严重肌肉脂肪变性与纤维化进展显著相关(HR 2.49;95%CI 1.15-5.40和HR 2.09;95%CI 1.01-4.34,对应不同纤维化进展定义)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Sarcopenia and myosteatosis are associated with advanced nonalcoholic fatty liver disease (NAFLD). However, muscle alterations in early stage NAFLD remain unclear. METHODS: Patients with nonalcoholic fatty liver (NAFL) or early nonalcoholic steatohepatitis (NASH) without significant fibrosis were selected from a prospective biopsy-proven NAFLD cohort (N = 338). The skeletal muscle index and mean muscle attenuation (MA) were measured using abdominal fat computed tomography at the third lumbar vertebra level. Severe myosteatosis was defined as the lowest quartile of sex-stratified MA values. RESULTS: Patients with early NASH (n = 87) had lower MA (45.61 ± 6.45 vs 47.48 ± 5.85 HU; P = .028) than patients with NAFL (n = 251) but a similar skeletal muscle index. Patients with more severe lobular inflammation and hepatocellular ballooning had lower MA (P = .003 and P = .041, respectively). The severe myosteatosis prevalence was higher in early NASH than in NAFL (33.3% vs 21.1%; P = .029). Patients with severe myosteatosis were more likely to have early NASH in multivariable analysis adjusted for age, sex, and metabolic factors (odds ratio, 2.45; 95% confidence interval (CI), 1.24-4.86), which was maintained after adjustment for visceral fat amount (odds ratio, 2.44; 95% CI, 1.22-4.89). During a median 29-month follow-up, 170 patients underwent repeated transient elastography. Fibrosis progression-an increase in liver stiffness measurement >2 kPa or second liver stiffness measurement ≥7 kPa-was found in 28 and 31 individuals. Severe myosteatosis was significantly associated with fibrosis progression after adjustment for various confounders (hazard ratio, 2.49; 95% CI, 1.15-5.40 and hazard ratio, 2.09; 95% CI, 1.01-4.34 for different fibrosis progression definitions). CONCLUSIONS: Severe myosteatosis is significantly associated with early NASH and fibrosis progression in early stage NAFLD.
引用
- Hsieh YC, Joo SK, Koo BK, et al. Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression. Clin Gastroenterol Hepatol. 2022. PMID: 35101634. doi:10.1016/j.cgh.2022.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。